{"id":"W2245655230","doi":"10.1200/jco.2007.25.18_suppl.15506","title":"The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Subset analysis of patients (pts) with brain metastases (BM)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Internal medicine; Renal cell carcinoma; Adverse effect; Population; Clinical endpoint; Clinical trial; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008162683,0.0002276186,0.002382191,0.0003532291,0.00009585617,0.00001911454,0.0003473022,0.0002043753,0.0001362496],"category_scores_gemma":[0.00279805,0.0001129512,0.001195475,0.0007791643,0.0003565609,0.0001504695,0.00007629648,0.0006479205,0.000002305522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001368807,"about_ca_system_score_gemma":0.0009200497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004398253,"about_ca_topic_score_gemma":0.0004712075,"domain_scores_codex":[0.994294,0.0009609865,0.003294783,0.0002744402,0.0007868842,0.0003889058],"domain_scores_gemma":[0.9852437,0.009218216,0.003769986,0.0004332597,0.0008626342,0.0004721776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4103521,0.01177177,0.313289,0.000040084,0.009401431,0.001293707,0.0001458331,0.0002196495,0.00009684778,0.0001046552,0.00441181,0.2488732],"study_design_scores_gemma":[0.1624189,0.05287103,0.7359135,0.00003574807,0.01259686,0.00003623862,0.000322895,0.00003412382,0.001204615,0.00008820405,0.03431733,0.0001605574],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948651,0.0004638534,0.0006885807,0.002373482,0.0005010834,0.0005336756,0.00005167671,0.000005742201,0.0005168663],"genre_scores_gemma":[0.9953142,0.000177235,0.002915709,0.001046905,0.0003092047,0.000006580437,0.00005278388,0.00002017444,0.000157239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4226245,"threshold_uncertainty_score":0.4606014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1106194677367489,"score_gpt":0.4725009566384316,"score_spread":0.3618814889016827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}